Date

The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").

On March 20, 2020, the MHD added 2 additional albuterol inhalers to the preferred drug list for a total of 4 preferred albuterol inhalers. Effective July 9, 2020, based on feedback from manufacturers and the supply chain the MHD changed the preferred drug list to 2 preferred albuterol inhalers. The current preferred albuterol inhalers are: ProAir HFA and Proventil HFA.